Some Radiologists Overestimate Mammography Skills
Radiologists have a higher level of confidence in their ability to interpret mammograms than their performance may indicate.
Radiologists have a higher level of confidence in their ability to interpret mammograms than their performance may indicate, said researchers in a study in the September issue ofAmerican Journal of Roentgenology.
The researchers in 2005 and 2006 mailed surveys to radiologists at six Breast Cancer Surveillance Consortium registries; 174 radiologists completed and returned the survey. They were asked to estimate their false-positive and cancer detection rates, and positive predictive value biopsy recommendation (PPV2) for screening mammography. The estimates were compared with their actual findings.
Most radiologists accurately estimated their cancer detection and recall rates: 74 percent and 78 percent, respectively. But fewer radiologists accurately estimated their false-positive rate (19 percent) and PPV2 (26 percent), researchers said.
According to the study:
• 43 percent of the radiologists reported recall rates that were similar to their actual rates, and 31 percent reported lower rates.
• 52 percent reported similar false-positive rates and 33 percent reported lower rates.
• 72 percent reported each similar cancer detection rates and PPV2 rates, but 23 percent reported higher cancer detection rates, while 38 percent reported higher PPV2 rates.
“Estimation accuracy did not differ by radiologist characteristics, except that radiologists who interpreted 1,000 or fewer mammograms annually were less accurate at estimating their recall rates,” the authors added.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
